Table of Contents Table of Contents
Previous Page  222 / 1224 Next Page
Information
Show Menu
Previous Page 222 / 1224 Next Page
Page Background

3 x 9.5 Gy

Postow et al:

NEJM 2012;366:925

Ipilumimab is an antibody aginst the T-cell CLTA4 receptor.

Inhibits the negative feed-back of cytotoxic T-lymphocytes